Qingyi Hou
YOU?
Author Swipe
View article: FCFDiff-Net: full-conditional feature diffusion embedded network for 3D brain tumor segmentation
FCFDiff-Net: full-conditional feature diffusion embedded network for 3D brain tumor segmentation Open
The proposed FCFDiff-Net provides an efficient and robust solution for 3D BraTS, outperforming existing models in terms of accuracy and robustness. Future work will focus on exploring the model's generalization capabilities and conducting …
View article: Diff‐<scp>CFFBNet</scp>: Diffusion‐Embedded Cross‐Layer Feature Fusion Bridge Network for Brain Tumor Segmentation
Diff‐<span>CFFBNet</span>: Diffusion‐Embedded Cross‐Layer Feature Fusion Bridge Network for Brain Tumor Segmentation Open
This study introduces the Diff‐CFFBNet, a novel network for brain tumor segmentation designed to address the challenges of misdetection in broken tumor regions within MRI scans, which is crucial for early diagnosis, treatment planning, and…
View article: Corrigendum to ‘Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging–Guided Focused Ultrasound–Induced Blood–Brain Barrier Opening in a Mouse Glioblastoma Model’ [Ultrasound in Med & Biol. 49 (2023) 1082-1090]
Corrigendum to ‘Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging–Guided Focused Ultrasound–Induced Blood–Brain Barrier Opening in a Mouse Glioblastoma Model’ [Ultrasound in Med & Biol. 49 (2023) 1082-1090] Open
View article: Immune cell identity behind the Ktrans mapping of mouse glioblastoma
Immune cell identity behind the Ktrans mapping of mouse glioblastoma Open
View article: Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging–Guided Focused Ultrasound–Induced Blood–Brain Barrier Opening in a Mouse Glioblastoma Model
Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging–Guided Focused Ultrasound–Induced Blood–Brain Barrier Opening in a Mouse Glioblastoma Model Open
View article: Dynamic <scp><sup>18</sup>F‐FDG PET</scp>/<scp>CT</scp> can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer
Dynamic <span><sup>18</sup>F‐FDG PET</span>/<span>CT</span> can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer Open
Major pathological response (MPR) is a potential surrogate for overall survival. We determined whether the dynamic changes in 18 F‐labeled fluoro‐2‐deoxyglucose positron emission tomography/computed tomography ( 18 F‐FDG PET/CT) were assoc…
View article: Molecular Identity Changes of Tumor-Associated Macrophages and Microglia after MRgFUS induced BBB Opening in a Mouse Glioblastoma Model
Molecular Identity Changes of Tumor-Associated Macrophages and Microglia after MRgFUS induced BBB Opening in a Mouse Glioblastoma Model Open
An orthotopically xenografted mouse GL26 glioma model (Ccr2 RFP/wt -Cx3cr1 GFP/wt ) was used to evaluate the effect of transient, focal opening of the Blood Brain Barrier (BBB) on the composition of tumor-associated macrophages and microgl…
View article: Visual Functional Defects in Patients with type 2 Diabetes Mellitus: A Questionnaire Based Cross-Sectional Study
Visual Functional Defects in Patients with type 2 Diabetes Mellitus: A Questionnaire Based Cross-Sectional Study Open
Purpose To determine the impact of type 2 diabetes mellitus (T2DM) on visual functions, identify different modifiers as risk or protective factors, and find out how these factors affect patients’ visual symptoms and vision-related quality …
View article: Non-invasive, neurotoxic surgery reduces seizures in a rat model of temporal lobe epilepsy
Non-invasive, neurotoxic surgery reduces seizures in a rat model of temporal lobe epilepsy Open
View article: A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer
A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer Open
Aim: Response Evaluation Criteria in Solid Tumors (RECIST) is occasionally insufficient for evaluation. We proposed a new prognostic index (NPI) that combines the standardized uptake value (SUV), metabolic tumor volume (MTV), and RE…
View article: Feasibility of intraoperative radiotherapy with X-rays for the treatment of superior sulcus tumours
Feasibility of intraoperative radiotherapy with X-rays for the treatment of superior sulcus tumours Open
Background Preoperative concurrent chemoradiotherapy (CCRT) followed by surgery has become the standard treatment for potentially resectable superior sulcus (SS) tumours. To date, intraoperative radiotherapy (IORT) for SS tumour treatment …
View article: P1.01-81 A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients with Lung Cancer
P1.01-81 A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients with Lung Cancer Open
View article: Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer Open
Background A subset of patients with non-small cell lung cancer (NSCLC) fosters mixed responses (MRs) to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) or chemotherapy. However, little is known about the clinical…
View article: 459P Comparison of predictive value between metabolic tumor volume and RECIST 1.1 assessed by 18F-FDG PET-CT in patients with lung cancer
459P Comparison of predictive value between metabolic tumor volume and RECIST 1.1 assessed by 18F-FDG PET-CT in patients with lung cancer Open